Simultaneous expression of CD38 and its ligand CD31 by chronic lymphocytic leukemia B-cells: Anecdotal observation or pathogenetic hypothesis for the clinical outcome?

Haematologica

Volumn 88, Issue 3, 2003, Pages 354-356

  Morabito, Fortunato ^a   Mangiola, Massimo ^a   Stelitano, Caterina ^a   Deaglio, Silvia ^b   Callea, Vincenzo ^a   Malavasi, Fabio ^b  

^a BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

B CLL; CD31; CD38; Monoclonal antibody

Indexed keywords

CD31 ANTIGEN; CD38 ANTIGEN;

ADULT; AGED; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL CONTACT; CELL DIFFERENTIATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MEMORY CELL; PATHOGENESIS; PROGNOSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; SURVIVAL RATE;

ADP-RIBOSYL CYCLASE; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD31; ANTIGENS, CD38; ANTIGENS, NEOPLASM; FEMALE; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROGNOSIS; TREATMENT OUTCOME;

EID: 0037346351     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Caligaris-Cappio F, Hamblin TJ. B-cell chronic lymphocytic leukemia: a bird of a different feather. J Clin Oncol 1999;17:399-408.
2. Mehta K, Shahid U, Malavasi F. Human CD38, a cell-surface protein with multiple functions. FASEB J 1996;10:1408-17.
3. Kumagai M, Coustan-Smith E, Malavasi F, Caligaris-Cappio F, Dellabona P, Richiardi P, et al. Characterization of a murine monoclonal antibody specific for human early lymphoemophoietic cells. Hum Immunol 1984;9:9-15.
4. Zupo S, Rugari E, Dono M, Taborelli G, Malavasi F, Ferrarini M. CD38 signaling by agonist monoclonal antibody prevents apoptosis of human germinal center B cells. Eur J Immunol 1994;24:1218-22.
5. , Pascual V, Liu YJ, Magalski A, de Bouteiller O, Banchereau J, Capra JD. Analysis of somatic mutation in five B cell subsets of human tonsil. J Exp Med 1994;180:329-39.
6. Morabito F, Mangiola M, Oliva B, Stelitano C, Callea V, Deaglio S, et al. Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia. Leuk Res 2001;25:927-32.
7. Morabito F, Mangiola M, Stelitano C, Deaglio S, Callea V, Malavasi F. Peripheral blood CD38 expression predicts time to progression in B-cell chronic lymphocytic leukemia after first-line therapy with high-dose chlorambucil. Haematologica 2002;87:217-8.
8. Deaglio S, Morra M, Mallone R, Ausiello CM, Prager E, Garbarino G, et al. Human CD38 (ADP-ribosyl-cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol 1998;160:395-402.
9. Vallario A, Chilosi M, Adami F, Montagna L, Deaglio S, Malavasi F, et al. Human myeloma cells express the CD38 ligand CD31. Br J Haematol 1999;105:441-4.
10. Deaglio S, Mallone R, Baj G, Arnulfo A, Surico N, Dianzani U, et al. CD38/CD31, a receptor/ligand system ruling adhesion and signaling in human leukocytes. Chem Immunol 2000;75:99-120.